Hormones, genes and the structure of sexual arousal

Behavioural Brain Research

Volumn 105, Issue 1, 1999, Pages 5-27

  Frohlich, Jonathan ^a,b   Ogawa, Sonoko ^a   Morgan, Maria ^a   Burton, Leslie ^b   Pfaff, Donald ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b FORDHAM UNIVERSITY   (United States)

Author keywords

Estrogenic hormones; Sexual arousal; Stimuli

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; APOMORPHINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BUTYROPHENONE; CAFFEINE; CENTRAL STIMULANT AGENT; CHLORDIAZEPOXIDE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DOPAMINE RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; HALOPERIDOL; NICOTINE; SCOPOLAMINE; THYROID HORMONE RECEPTOR; TRANQUILIZER;

BEHAVIOR; FEAR; HEREDITY; HUMAN; LOCOMOTION; LORDOSIS; MOTIVATION; MOUSE; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR GENE; REPRODUCTION; REVIEW; SEXUAL AROUSAL; SEXUAL BEHAVIOR; STARTLE REFLEX; TOUCH;

EID: 0032858962     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00079-0     Document Type: Article

References (211)

1. Adams L., Geyer M. LSD-induced alterations of locomotor patterns and exploration in rats. Psychopharmacology. 77:1982;179-182.
2. Adams L., Geyer M. A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats. Behav. Neurosci. 5:1985;881-900.
3. Aggleton J.P., Mishkin M The amygdala: sensory gateway to the emotions. Plutchick R., Kellerman H. Emotion: Theory, Research and Experience. 1986;981-999 Academic Press, Orlando.
4. Alexandeer G., DeLong P., Strick P. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:1986;357-381.
5. Andersen P.H., Gingrich J.A., Bates M.D., Dearry A., Falardeau P., Senogles S.E., Caron M.C. Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol. Sci. 11:1990;231-236.
6. Arnold F.J.L., DeLucas Bueno M., Shiers H., Hancock D.C., Evan G., Herbert J. Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotriopin-releasing facto in unstressed or stressed male rats. Neuroscience. 51:1992;377-390.
7. Baldessarini R.J Dopamine receptors and clinical medicine. Neve R.L., Neve K.A. The Dopamine Receptors. 1997;457-498 Humana Press, Totowa.
8. Becker J.B., Snyder P.J., Miller M.M., Westgate S.A., Jenuwine M.J. The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat. Pharmacol. Biochem. Behav. 27:1987;53-59.
9. Beninger R.J. The role of dopamine in locomotor activity and learning. Brain. Res. Rev. 6:1983;173-196.
10. Beninger R.J., Phillips A.G. The effect of pimozide on the establishment of conditioned reinforcement. Psychopharmacology. 68:1980;147-153.
11. Bergson C., Mrzljak L., Smiley J.F., Pappy M., Levenson R., Goldman-Rakic P.S. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in the primate brain. J. Neurosci. 15:1995;7821-7836.
12. Berlyne D.E Conflict, Arousal and Curiosity. 1960;McGraw-Hill, New York.
13. Berlyne D.E. Curiosity and exploration. Science. 153:1966;25-33.
14. Bernard J.F., Alden M., Besson J.M. The organization of the efferent projections from the pontine parabrachial area to the amygdaloid complex: a phaseolus vulgaris leucoagglutininn (PHA-L) study in the rat. J. Comp. Neurol. 329:1993;201-229.
15. Bethea C.L. Coloalization of progestin receptors with serotonin in raphe neurons of a macque. Neuroendocrinology. 57:1993;1-6.
16. Biegon A., Reches A., Snyder L., McEwen B. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 32:1983;2015-2021.
17. Bindra D. Neuropsychological interpretation of the effects of drive and incentive-motivation on general activity and instrumental behavior. Psychol. Rev. 75:1968;1-22.
18. Bindra D A Theory of Intelligent Behavior. 1976;Wiley, New York.
19. Bindra D., Spinner N. Responses to different degrees of novelty: the incidence of various activities. J. Exp. Anal. Behav. 1:1958;341-350.
20. Blackburn J.R., Phillips A.G., Fibiger H.C. Dopamine and preparatory behavior: I: effects of pimozide. Behav. Neurosci. 101:1987;352-360.
21. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 81:1972;281-290.
22. Boldry R.C., Willins D.L., Wallace L.J., Uretsky N.J. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA. Brain Res. 559:1991;100-108.
23. Boyd A.E., Reichlin S. Neural control of prolactin secretion in man. Psychoneuroendocrinology. 3:1978;113-130.
24. Broadbent D.E Decision and Stress. 1971;Academic Press, London.
25. Cabib S., Castellano C., Cestari V., Filibeck V., Puglisi-Allegra S. D1 and D2 receptor antagonists differentially affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology. 105:1991;335-339.
26. Callaway C.W., Wing L., Geyer M. Serotonin release contributes to the stimulant effects of 3,4, methylenedioxymethamphetamine in rats. J. Pharmacol. Exp. Ther. 254:1990;456-464.
27. Campbell A., Villavicencio A., Yeghiayan S., Balikian R., Baldessarini R. Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Res. 71:1997;55-62.
28. Campeau S., Davis M. Involvement of the central and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J. Neurosci. 15:1995;2301-2311.
29. Camper S.A., Saunders T.L., Kendall S.K. et al. Implementing transgenic and embryonic stem cell technology to study genetic expression, cell-cell interactions and gene function. Biol. Reprod. 52:1995;246-257.
30. Capobianco S., Hamilton L.W. Effects of interruption of limbic system pathways on different measures of activity. Physiol. Behav. 17:1976;65-72.
31. Chalmers D., Lovenberg T.W., DeSouza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
32. Chen Y.-F., Ramirez V.D. Prolactin stimulates dopamine release from male but not female rat striatal tissue superfused in vitro. Endocrinology. 111:1982;1704-1742.
33. Chrobak J.J., Napier T.C. Delayed non-match-to-sample performance in the radial arm maze: effects of dopaminergic and GABAergic agents. Psychopharmacology. 108:1992;72-78.
34. Clark C., File S. Selective neurotoxic lesions of the lateral septum: changes in social and aggressive behaviors. Pharmacol. Biochem. Behav. 17:1982;623-628.
35. Clark P.B.S., Jakubovic A., Fibiger H.C. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of D-amphetamine and apomorphine. Psychopharmacology. 96:1988;511-520.
36. Claus H., Bindra D. Reactions to novelty and stimulus change induced response decrement. Can. J. Psychol. 14:1960;101-110.
37. Crabbe J.C. Genetic differences in locomotor activation in mice. Pharmacol. Biochem. Behav. 25:1986;289-292.
38. Crooke S.T., Bennett C.F. Progress in antisense oligonucleotide therapeutics. Annu. Rev. Pharmacol. Toxicol. 36:1996;107-129.
39. Crowley W.R., O'Donohue T.L., Jacobowitz D.M. Sex differences in catecholamine content in discrete brain nuclei of the rat: effects of neonatal castration or testosterone treatment. Acta Endocrinol. 89:1978;20-28.
40. Dallman M.F., Akana S.F., Scribner K.A., Brandbury M.J., Walker C.D., Strack A.M.and, Cascio C.S. Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J. Neuroendocrinol. 4:1992;517-526.
41. Darnell A., Bremen J.D., Licino J., Krystal J., Nemeroff J., Owens M., Erdos J., Charney D.S. CSF levels of corticotropin releasing factor in chronic post-traumatic stress disorder. Soc. Neurosci. Abstr. 20:1994;17.
42. Davis M The mammalian startle response. Eaton R.C. Neural Mechanisms of Startle Behavior. 1984;287-351 Plenum, New York.
43. Davis M The potentiated startle response as a measure of conditioned fear and its relevance to the neurology of anxiety. Simon P., Soubrie P. Animal Models of Psychiatric Disorders. 1988;61-89 Wildlocher, Paris.
44. Davis M., Kehne J., Commissaris R., Geyer M Effects of hallucinogens on unconditioned behaviors in animals. Jacobs B.L. Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives. 1984;35-76 Raven Press, New York.
45. Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 17:1994;208-214.
46. Davis W.M., Smith S.G. Effect of haloperidol in (+)-amphetamine self administration. J. Pharm. Pharmacol. 27:1975;540-542.
47. Deakin J., Green A. The effects of putative 5-hydroxytryptamine antagonists on the behavior produced by administration of tranycypromine and L-dopa to rats. Br. J. Pharmacol. 64:1978;201-209.
48. DeFries J.C., Wilson J.R., McClearn G.E. Open-field behavior in mice: selection response and situational generality. Behav. Genet. 1:1970;195-211.
49. Dellovade, T, Kia, H, Zhu, Y-S and Pfaff, D. Thyroid Hormone coadministration inhibits the estrogen-stimulated elevation of preproenkephalin mRNA in female rat hypothalamic neurons. Neuroendocrinology, in press.
50. Dellovae T., Zhu Y., Krey L., Pfaff D.W. Thyroid hormone and estrogen interact to regulate behavior. Proc. Natl. Acad. Sci. USA. 93:1996;12581-12586.
51. Dellovade T., Zhu Y., Pfaff D.W. Thyroid hormone and estrogen affect oxytocin gene expression in hypothalamic neurons. J. Neurodendocrinol. 11:1998;1-10.
52. Deutsch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
53. DiPaolo T., Carmichael R., Labrie F., Raynaud J.P. Effects of estrogens on the characteristics of [3H]RU24213 binding in rat anterior pituitary gland and brain. Mol. Cell. Endocrinol. 16:1979;99-112.
54. DiPaolo T., Rouillard C., Bedard P. 17 β-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur. J. Pharmacol. 117:1985;197-203.
55. Dirlam D.K. The effects of septal, thalamic, and tegmental lesions on general activity in the hooded rat. Can. J. Psychol. 23:1969;303-313.
56. Drago J., Gerfen C.R., Lachowitz J.E. et al. Altered striatal function in mutant mouse lacking D1A dopamine receptors. Proc. Natl. Acad. Sci. USA. 91:1994;12564-12568.
57. Dringenberg H., Hargreaves E., Baker G., Cooley R.and, Vanderwolf C. p-Chlorophenylalanineinducedserotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits. Behav. Brain Res. 68:1995;229-237.
58. Duffy E Activation and Behavior. 1962;Wiley, New York.
59. Dunn A.J., Berridge C.W. Physiological and behavioral response to corticotropin releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
60. Dupont A., DiPaolo T., Gagne B., Barden N. The effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of ovariectomized mice. Neurosci. Lett. 22:1981;69-74.
61. Easterbrook J.A. The effect of emotion on cue utilization and the organization of behaviour. Psychol. Rev. 66:1959;183-201.
62. Engelmann M., Thrivikraman Y., Nemeroff C., Montkowski A., Landgraf R., Holsboer F., Plotsky P. Endocrine and behavioral effects of airpuff-startle in rats. Psychoneuroendocrinology. 21:1996;391-400.
63. Ernst A.M. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia. 10:1967;316-323.
64. Ettenberg A. Dopamine, neuroleptics, and reinforced behavior. Neurosci. Biobehav. Rev. 13:1989;105-112.
65. Ettenberg A., Horvitz J.C. Pimozide prevents the response-reinstating effects of water reinforcement in rats. Pharmacol. Biochem. Behav. 37:1990;465-469.
66. Euvrard C., Labrie F., Boissier J.R. Effects of moxestrol on halperidol-induced changes in striatal acetylcholine levels and dopamine turnover. Commun. Psychopharmacol. 3:1979;329-334.
67. Eysenck M Attention and Arousal. 1982;Springer-Verlag, New York, Berlin, Heidelberg.
68. Fanslow M.S., Kim J.J. Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D.L-2amino-5 phosphonovaleric acid to the basolateral amygdala. Behav. Neurosci. 108:1994;210-212.
69. Fibiger H.C., Campbell B.A. The effect of parachlorophenylalanine on spontaneous locomotor activity in the rat. Neuropharmacology. 10:1971;25-32.
70. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia. 44:1975;53-59.
71. File S.E., Zangrosso H., Sanders F., Mabbutt P. Raised corticosterone in the rat after exposure to the elevated plus maze. Psychopharmacology. 113:1994;543-546.
72. Fink J.S., Smith G.P. Mesolimbicortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats. Brain Res. 199:1980;359-384.
73. Flynn J.P. Patterning mechanisms, patterned reflexes, and attack behavior in cats. Nebraska Symposium on Motivation. 20:1972;125-153.
74. Fowler S.C. Neuroleptics produce within-session response decrements: facts and theories. Drug Dev. Res. 20:1990;101-116.
75. Freeman A.S., Bunney B.S. Activity of A9 and A10 dopaminergic neurons in unrestrainedrats: further characterization and effects of apomorphime and cholecystokinin. Brain Res. 405:1987;46-55.
76. Fujiwara H. Comparitive studies of sulpiride and classical neuroleptics of catalepsy, locomotor activity, and brain dopmaine metabolism in mice. Pharmacol. Biochem. Behav. 41:1992;301-308.
77. Gasbarri A., Sulli A., Innocenzi R., Pacitti C., Brioni J. Spatial memory impairmentinduced by lesion of the mesohippocampal dopaminergic system in the rat. Neuroscience. 74:1996;1037-1044.
78. Geyer M Heterogeneous functions of discrete serotonergic pathways in the brain. Usdin E., Mandell A.J. Biochemistry of Mental Disorders. 1978;233-260 Marcel Dekker, New York.
79. Geyer M. Serotonergic functions in arousal and motor activity. Behav. Brain. Res. 73:1996;31-35.
80. Geyer M., Calloway C Behavioral pharmacology of ring-substituted amphetamine analogs. Cho A.K., Segal D.S. Amphetamine and its Analogs: Neuropsychopharmacology Toxicology and Abuse. 1994;177-208 Academic Press, New York.
81. Geyer M., Krebs K.M. Serotonin receptor involvement in an animal model of the acute affects of hallucinogens. NIDA Res. Monogr. Ser. 146:1994;124-156.
82. Geyer M.A., Light R.K., Rose G.J., Petersen L.R., Horwitt D., Adams L., Hawkins R. A characteristic effect of hallucinogens on investigatory responding in rats. Psychopharmacology. 65:1979;35-40.
83. Geyer M.A., Paulus M. Multivariate and non-linear approaches to the characterization of drug effects on the locomotor and investigatory behavior of rats. NIDA Res. Monogr. Ser. 124:1992;203-236.
84. Geyer M., Petersen L.R., Rose G.J. Effects of serotonergic lesions on investigatory responding by rats in a holeboard. Behav. Neural. Biol. 30:1980;160-177.
85. Geyer M., Puerto A., Menkes D.B., Segal D.S., Mandel A.J. Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res. 106:1976;256-270.
86. Geyer M., Russo P., Masten V. Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol. Biochem. Behav. 25:1986;277-288.
87. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopaminereceptors. Annu. Rev. Neurosci. 16:1993;299-321.
88. Gold L.H., Koob G.F., Geyer M. Stimulant and hallucinogenic behavioral profilesof 3,4,-methylenedioxymetamphetamine and N-ethyl-3,4,-methylenedioxymetamphetamine rats. J. Pharmacol. Exp. Ther. 247:1988;547-555.
89. Gordon J.H. Modulation of apomorphine-induced steryotypy by estrogen: time course and dose response. Brain Res. Bull. 5:1980;679-682.
90. Gordon J.H., Gorski R.A., Borison R.L., Diamond B.I. Postsynaptic efficacy of dopamine: possible suppression by estrogen. Phamacol. Biochem. Behav. 12:1980;515-518.
91. Godron J.H., Perry K.O. Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity. Brain Res. Bull. 10:1983;425-428.
92. Gordon J.H., Shellenberger M.K. Regional catecholamine content in the rat brain: differences and correlation with motor activity. Neuropharmacology. 13:1974;129-137.
93. Grahme-Smith D.G. Studies in-vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18:1971;1053-1066.
94. Grandy D.K., Civelli O. G-protein-coupled receptors: the new dopamine receptor subtypes. Curr. Opin. Neurobiol. 2:1992;275-281.
95. Green A.R., Guy A.P., Gardner C.R. The behavioral affects of RU 24969, a suggested 5-HT-1B receptor agonist in rodents and the effect on the behavior of treatments with antidepressants. Neuropharmacology. 23:1984;655-661.
96. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology. 15:1990;97-111.
97. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn. 14:1990;26-43.
98. Hampson E., Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav. Neurosci. 102:1988;456-459.
99. Hebb D.O. Drives and the C.N.S. (conceptual nervous system). Psychol. Rev. 62:1955;243-254.
100. Hebb D.O Distinctive features of learning in the higher animal. Delafresnaye J.F. Brain Mechanism and Learning. 1962;Oxford University Press, London.
101. Herkenham M., Moon-Edly S., Stuart J. Cell clusters in the nucleus accumbens of the rat, and the mosaic relationship of opiate receptors, acteylcholinesterase and subcortcal afferent terminations. Neuroscience. 11:1984;561-593.
102. Hooks M.S., Kalivas P.W. Involvement of dopamine and excitatory amino acid transmission in novelty induced motor activity. J. Pharmacol. Exp. Ther. 269:1994;976-988.
103. Horvitz J.C., Ettenberg A. Conditioned incentive properties of a food-paired stimulus remain intact during dopamine receptor blockade. Behav. Neurosci. 105:1991;536-541.
104. Horvitz J.C., Stewart T., Jacobs B. Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat. Brain Res. 759:1997;251-258.
105. Hutt S.J., Frank G., Myychalkiw W., Hughes M. Perceptual-motor performance during the menstrual cycle. Horm. Behav. 14:1980;116-125.
106. Iwata J., Chida K., LeDoux J.E. Cardiovascular response elicited by stimulation of neurons in the central amygdaloid nucleus in awake but not anesthatized rats resemble conditioned emotional responses. Brain Res. 418:1987;188-193.
107. Jacobs B.L. An animal behavior model for studying central serotonergic synapses. Life Sci. 19:1976;777-786.
108. Jacobs B.L Postsynaptic serotonergic action of hallucinogens. Jacobs B.L. Hallucinogens: Neurochemical, Behavioral and Clinical Perspectives. 1984;183-202 Raven Press, New York.
109. Jacobs B.L., Klemfuss H. Brain stem and spinal cord mediation of a serotonergic behavioral syndrome. Brain Res. 100:1975;450-457.
110. Jacobs B.L., Trimbach C., Eubanks E.E., Trulson M. Hippocampal mediation of raphe lesion- and PCPA-induced hyperactivity in the rat. Brain Res. 94:1975;253-261.
111. Jacobs B.L., Wise W.D., Taylor K.M. Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res. 79:1974;353-361.
112. Johnson M., Crowley W. Acute effects of estradiol on circulating lueinizing hormone and prolactin concentrations and on serotonin turnover in individual brain nuclei. Endocrinology. 113:1983;1935-1941.
113. Jori A., Colturani F., Dolfini E., Rutczynski M. Neuroendocrinology. 21:1976;262-266.
114. Khan A., Shim H., Mirolo M., Horatia A., Douglas R., Tucker G. TRH effects on arousal, locomotor activity and spontaneous alteration in ECS post-ictal state. Psychopharmacology. 106:1992;570-571.
115. Kahneman D Attention and Effort. 1973;Prentice Hall, Englewood Cliffs.
116. Kandel E., Schwartz J., Jessell T Principles of Neural Science. Third Edition:1991;Aggelton and Lance, Norwalk.
117. Kapp B.S., Whalen P.J., Supple W.F.-Jr., Pascoe J.P Amygdaloid contributions to conditioned arousal and sensory information processing. Aggelton J.P. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. 1992;229-254 Wiley, New York.
118. Kelly M., Rubinstein M., Phillips T. et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosci. 18:1998;3470-3479.
119. Koe K.B., Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 194:1966;499-516.
120. Kohler C., Lorens S. Open-field activity and avoidance behavior following serotonin depletion: a comparison of the effects of para-chlorophenylalanine and electrolytic midbrain lesions. Pharmacol. Biochem. Behav. 8:1978;223-233.
121. Kopell B.S., Lunde D.T., Clayton R.B., Moos R.H. Variations in some measures of arousal during the menstrual cycle. J. Nerv. Ment. Dis. 148:1969;180-187.
122. Koretsky A.P. Investigation of cell physiology in the animal using transgenic technology. Am. J. Physiol. 262:1992;C261-C275.
123. Kueng W., Wirz-Justice A., Menze R., Chapuis-Arndt E. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat. Neuroendocinology. 21:1976;289-296.
124. Larson E.R., Ariano M.A. D3 and D2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures. Synapse. 20:1995;325-337.
125. Lat J The spontaneous exploratory reactions as a tool for psychopharmacological studies: a contribution towards a theory of contradictory results in psychopharmacology. Mikhelson M.Y., Longo V.G., Votava Z. Pharmacology of Conditioning, Learning and Retention. 1965;47-66 Pergamon Press, Oxford.
126. LeDoux, J.E. In search of an emotional system in the brain: leaping from fear to emotion and consciousness, In: M.S. Gazzaniga (Ed.), Handbook of Cognitive Neuroscience, MIT Press, Cambridge, 1996, pp.1049-1061.
127. LeDoux J.E., Cicchetti P., Xagorarias A., Romanaski L. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci. 10:1990;1062-1069.
128. Lee Y., Davis M. Role of the septum in the excitatory effect of corticotropin-releasinghormone on the ac oustic startle reflex. J. Neurosci. 17:1997;6424-6433.
129. Lee Y., Lin Y.P., Yin T.H. Effects of lateral and medial septal lesions on various activity and reactivity measures in the rat. Physiol. Behav. 42:1988;97-102.
130. Lee Y., Tsai M.J., Chai C.Y. Stress selectively influences center region activity of mice in an open field. Physiol. Behav. 37(1986):1986;659-662.
131. Levine S., Ursin H What is stress? Brown M., Koob G., Rivier C. Stress, Neurobiology and Neuroendocrinology. 1991;3-21 Marcel Decker, New York.
132. Liang K.C., Meli K.R., Campeau S., Falls W.A., Miserendino M.J.D., Davis M. Lesions of the central nucleus of the amygdala, but not paraventricular nucleus of the hypothalamus block the excitatory effect of corticotropin-releasing factor on the acoustic startle reflex. J. Neurosci. 12:1992;2313-2320.
133. Liebman J.M. Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology. Neurosci. Biobehav. Rev. 7:1982;45-72.
134. Lindvall O., Bjorklund A Anatomy of the dopaminergic systems in the rat brain. Roberts P.J., Woodruff G.N., Iverson L.L. Dopamine. 1978;1-24 Raven Press, New York.
135. Ljungberg T., Ungerstedt U. Automatic registration of behavior related to dopamine and noradrenaline transmission. Eur. J. Pharmacol. 36:1976;181-188.
136. Lorens S. Some behavioral effects of serotonin depletion depend on method: a comparisonof 5,7,-dihydroxytryptamine, p-chlorophenylaline, p-chloroamphetamine, and electrolytic raphe lesions. Ann. N.Y. Acad. Sci. 305:1978;532-555.
137. Lucki I., Ward H.R., Frazer A. Effect of 1-(m)chlolphenyl-piperazine and 1-(m)-trifluoromethylphenylpiperazineon locomotor activity. J. Pharmacol. Exp. Ther. 249:1989;115-164.
138. Lynch G.S. Separable forebrain systems controlling different manifestations of spontaneous activity. J. Comp. Physiol. Psychol. 70:1970;48-59.
139. MacLeod R.M Regulation of prolactin secretion. Martini L., Ganong W.F. Front. Neuroendocrinol. 4:1976;169-194 Raven Press, New York.
140. Marsden C.A., Curzon G. Studies on the behavioral effects of tryptophan and p-chlorophenylalanine. Neuropharmacology. 15:1976;165-171.
141. Matthews T., Grigore M., Tang L., Doat M., Kow L., Pfaff D.W. Sexual reinforcement in the female rat. J. Exp. Anal. Behav. 68:1997;399-410.
142. Meibach R., Siegel A. Efferent connections of the septal area in the rat: an analysis utilizing retrograde and anterograde transport methods. Brain Res. 119:1977;1-20.
143. Melia K.R., Sananes C.B., Davis M. Lesions of the central nucleus of the amygdala block the excitatory effects of septal ablation on the acoustic startle reflex. Physiol. Behav. 51:1991;175-180.
144. Meredith G., Pennartz C., Groenewegen H. The cellular framework for chemical signaling in the nucleus accumbens. Prog. Brain Res. 99:1993;3-24.
145. Meyer M.E., Van Hartsveldt C., Potter T.J. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK and F 38393 in rats. Synapse. 13:1993;310-314.
146. Moore K.E., Wuerthele S.M. Regulation of nigrostriatal and tuberoinfidibular-hypophyseal dopaminergic neurons. Prog. Neurobiol. 13:1979;325-359.
147. Morgan C.A., Grillon C., Southwick S.M., Davis M., Charney D.S. Fear-potentiated startle in posttraumatic stress disorder. Biol. Psychiatry. 38:1995;378-385.
148. Mink J.W., Thatch W.T. Basal ganglia intrinsic circuits and their role in behavior. Curr. Opin. Neurobiol. 3:1993;950-957.
149. Mirsky A.H., Rosvold H.E The use of psychoactive drugs as a neuropsychological tool in studies of attention in man. Uhr L., Miller J.G. Drugs and Behavior. 1960;375-392 Wiley, New York.
150. Miserendio M., Sananes C., Melia K., Davis M. Blocking of acquisition but not expression of conditioned fear-potentiated startle by NDMA antagonists in the amygdala. Nature. 345:1990;716-718.
151. Mittman S.M., Geyer M.A. Effects of 5-HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology. 98:1989;321-329.
152. Naatanen R The inverted-U relationship between activation and performance: a critical review. Kornblum S. Attention and Performance, volume IV. 1973;Academic Press, London.
153. Naik S.R., Kelkar M.R., Sheth U.K. Attenuation of stereotyped behaviour by sex steroids. Psychopharmacology. 57:1978;211-214.
154. Nauta W., Smith G., Faull R., Domesick V. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience. 3:1978;385-401.
155. Neill J.D Neuroendocrine regulation of prolactin secretion. Martini L., Ganong W.F. Front. Neuroendocrinol. 6:1980;129-155 Raven Press, New York.
156. Nestler E.J. Hard target: understanding dopaminergic transmission. Cell. 79:1994;923-926.
157. Oberlander C., Blaquiere B., Pujol J.F. Distinct functions for dopamine and serotonin in locomotor behavior: evidence using the 5HT1 agonist RU24969 in globus pallidus-lesioned rats. Neurosci. Lett. 67:1986;113-118.
158. Oberlander C., Demassey Y., Verdu A., Van de Velde D., Bardelay C. Tolerance to the serotonin 5-HT-1B agonist RU 24969 and effects on dopaminergic behavior. Eur. J. Pharmacol. 139:1987;205-214.
159. Ogawa S., Pfaff D.W. Application of antisense DNA method for the study of molecular bases of brain function and behavior. Behav. Genet. 26:1996;279-292.
160. Paylor R., Tracy R., Wehner J., Rudy J. DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behav. Neurosci. 108:1994;810-817.
161. Perkins N.A., Westfall T.C. The effect of prolactin on dopamine release from rat striatum and medial basal hypothalamus. Neuroscience. 3:1978;59-63.
162. Peroutka S.J. Pharmacological differentiation and characterization of 5-HT-1A, 5-Ht-1B, and 5-HT-1C binding sites in rat frontal cortex. J. Neurochem. 47:1986;529-540.
163. Peroutka S.J., Snyder S.H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide, and [3H]spiroperidol. Mol. Pharmacol. 16:1979;687-699.
164. Pfaff D.W. Neurobiological mechanisms of sexual motivation. Pfaff D.W. The Physiological Mechanisms of Motivation. 1982;287-317 Springer-Verlag, New York.
165. Pfaff D.W. Drive: Neural and Molecular Mechanisms for Sexual Motivation. 1999;The MIT Press, Cambridge, Mass.
166. Pfaff D.W. Introduction: Genetic influences on the nervous system and behavior. Pfaff D.W., Berrettini W., Joh T., Maxson S. Genetic Influences on Neural and Behavioral Function. 1999;CRC Press, Boca Raton.
167. Rempel N., Callaway C.W., Geyer M. Serotonin 5-HT1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology. 8:1993;201-212.
168. Robertson B., Baker G., Vanderwolf C. The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior. Brain Res. 555:1991;265-275.
169. Robbins T.W., Everett B.J Arousal systems and attention. Gazzaniga M.S. Handbook of Cognitive Neuroscience. 1996;703-720 MIT Press, Cambridge.
170. Robledo P., Koob G.F. Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav. Brain. Res. 55:1993;159-166.
171. Rosen J.B., Schulkin J. From normal fear to pathological anxiety. Psychol. Rev. 105:1998;325-350.
172. Rosencrans J.A. Forebrain biogenic amine function in high and low active female rats. Physio. Behav. 5:1970;453-458.
173. Roth K.A., Katz R.J. Stress, behavioral arousal, and open field activity: a reexamination of emotionality in the rat. Neurosci. Biobehav. Rev. 3:1980;247-263.
174. Rubenstein M., Gershanik O., Stefano F. Different roles of D1 and D2 dopamine receptors involved in locomotor activity of supersensitive mice. Eur. J. Pharmacol. 148:1988;419-426.
175. Saul'skaya N.B., Marsden C.A. Glutimate levels in the nucleus accumbens in a conditioned emotional response. Neurosci. Behav. Physiol. 27:1997;548-551.
176. Schiorring E. An open field study of locomotor activity in amphetamine-treated rats. Psychopharmacology. 66:1979;281-287.
177. Shillito E.E Exploratory behavior in the short-tailed vole. Lester D. Explorations in Exploration. 1969;61-72 Van Nostrand, New York.
178. Siegel A., Schubert K., Shaikh M.B. Neurochemical mechanisms underlying amygdaloid modulation of aggressive behavior in the cat. Aggr. Behav. 21:1995;49-62.
179. Smith D.R., Striplin C.D., Geller A.M., Mailman R.B., Drago J., Lawler C.P., Gallagher M. Behavioral assessment of mice lacking D1A dopamine receptors. Neuroscience. 86:1998;135-146.
180. Soubrie P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav. Brain Sci. 9:1986;319-364.
181. Strange P.E. New insights into dopamine receptors in the central nervous system. Neurochem. Int. 22:1993;223-236.
182. Starr B.S., Starr M.S., Kilpatrick I.C. Behavioral role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience. 22:1987;179-188.
183. Steinfels G., Heyem J., Strecker R., Jacobs B. Raphe unit activity in freely moving cats is altered by manipulations of central but not peripheral motor systems. Brain Res. 279:1983;77-84.
184. Swanson L., Cowan W.M. The connections of the septal region in the rat. J. Comp. Neurol. 186:1979;621-656.
185. Swerdlow N.R., Britton K.T., Koob G.F. Potentiation of acoustic startle by corticotropin releasing factor (CRF) and by fear are both reversed by alpha-helical CRH (9-41). Neuropsychopharmacology. 2:1989;285-292.
186. Swerdlow N.R., Geyer M.A., Vale W.W., Koob G.F. Corticotropin releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology. 88:1986;147-152.
187. Tabakoff B., Kiianmaa K. Does tolerance develop to the activating as well as the depressant effects of ethanol? Pharmacol. Biochem. Behav. 17:1982;1073-1076.
188. Takahashi L.K., Kalin N.H., Vanden Burgt J.A., Sherman J.E. Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav. Neurosci. 103:1989;648-654.
189. Thayer R.E. Activation states as assessed by verbal reports and four psychophysiological variables. Psychophysiology. 7:1970;86-94.
190. Thiebot M.H., Hamon M., Soubrie P. Attenuation of induced-anxiety in rats by chlordiazepoxide: role of raphe dorsalis benzodiazapine binding sites, and serotonergic neurons. Neuroscience. 7:1982;2287-2294.
191. Thrivikraman, K.B. and Plotsky, P.M. Stressor-specific susceptibility of HPA-axis activity to fast feedback in conscious rats. Endocrine Society, 75th Annual Meeting, (1993) Abstract #357.
192. Thrivikraman, K.V., Su, Y. and Plotsky, P.M. (1994). Modality-specific fast-feedback regulation of HPA axis. First World Congress On Stress, Bethesda, MD, Abstract # 257.
193. Thrivikraman K.V., Su Y., Vergnani L., Mulchahey J.J., Plotsky P.M. Stressor Specific patterns of Fos protein expression in the rat brain in relation to HPA axis activation. Soc. Neurosci. Abstr. 19:1993;414.
194. Tricklebank M., Middlemiss D., Neill J. Pharmacological analysis of the behavioral and thermoregulatory effects of the putative 5-HT-1B receptor agonist, Ru-24969, in the rat. Neuropharmacology. 25:1986;877-886.
195. Trulson M.E., Jacobs B.L. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res. 163:1979;135-150.
196. Turner B.J The cortical sequence and terminal distribution of sensory related afferents to the amygdaloid complex of the rat and monkey. Aggelton J.P. The Amygdaloid Complex. 1981;51-62 Elsevier, Amsterdam.
197. Vanderwolf C.H. Cerebral activity and behavior: control by central cholinergic and serotonergic systems. Int. Rev. Neurobiol. 30:1988;225-340.
198. Vanderwolf C.H., McLauchlin M., Dringenberg H., Baker G.B. Brain structures involved in the behavioral stimulant effect of central serotonin
199. Van Hartesveldt C., Joyce J. Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10:1986;1-14.
200. Walley R.E., Weiden T.D. Lateral inhibition and cognitive masking: a neuropshycological theory of attention. Psychol. Rev. 80:1973;284-302.
201. Walker C., Trottier G., Rochford J., Lavallee D. Dissociation between behavioral and hormonal responses to the forced swim stress in lactating rats. J. Neuroendocrinol. 7:1995;615-622.
202. Wehner J.M., Sleight S., Upchurch M. Hippocampal protiein kinase activity is reduced in poor spatial learners. Brain Res. 523:1990;181-187.
203. Weinberger N.M., Diamond D.M. Physiological plasticity in auditory cortex: rapid induction by learning. Prog. Neurobiol. 29:1987;1-55.
204. White N.M., Packard M.G., Hiroi N. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into the nucleus accumbens. Psychopharmacology. 103:1991;271-276.
205. Xu M., Hu X., Cooper D.C., Moratalla R., Grayiel A.M., White F.J., Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 79:1994;945-955.
206. Xu M., Moratalla R., Gold L., Hiroi N., Koob G., Graybiel A., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
207. Yerkes R.M., Dodson J.D. The relation of strength of stimulus to rapidity of habit-formation. J. Comp. Neurol. Psychol. 18:1908;459-482.
208. Yurek D.M., Hipkens S.B. Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior. Brain Res. 623:1993;56-64.
209. Zhu Y., Ling Q., Cai L., Imperato-McGinley J., Pfaff D.W. Regulation of preproenkephalin (PPE) gene expression by estrogen and its interaction with thyroid hormone. Soc. Neurosci. Abstr. 23:1997;798.
210. Zhu Y., Yen P., Chin W., Pfaff D.W. Estrogen and thyroid hormone interaction on regulation of gene expression. Proc. Natl. Acad. Sci. USA. 93:1996;12587-12592.
211. Zhou L.W., Zhang S.P., Qin Z.H., Weiss B. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor mediated behavior and the expression of D2 dopamine receptors in the mouse striatum. J. Pharmacol. Exp. Ther. 268:1994;1015-1023.